For food makers, this shift presents opportunities to lead with better-for-you innovation and more permissibly indulgent, satisfying and nutritionally balanced formulations
But stronger results on paper do not always mean it is the better fit for your body, symptoms or side effect profile
Liposomes, these phospholipid-based vesicles, are revolutionizing drug delivery and nanotechnology
Costanza Alciati, a pharma analyst at GlobalData, told BioSpace in an email that GLP-1s will definitely dominate the market in the near future, but new entrants into the space are already looking for the next drug class that could revolutionize the space. Companies taking an alternative approach are forecast to capture only a very small portion of the obesity marketroughly 6.3%across the seven major markets (U.S., France, Germany, Italy, Spain, UK and Japan) by the end of 2031, according to Sara Reci, a senior analyst at GlobalData